Abstract
Circulating inflammatory factors and endothelial dysfunction have been proposed to contribute to the pathophysiology of hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome. To date, the occurrence of neurological complications in these women has been reported, but few studies have examined whether impairment in blood–brain barrier (BBB) permeability or cerebrovascular reactivity is present in women having HELLP syndrome. We hypothesized that plasma from women with HELLP syndrome causes increased BBB permeability and cerebrovascular dysfunction. Posterior cerebral arteries from female nonpregnant rats were perfused with 20% serum from women with normal pregnancies (n = 5) or women with HELLP syndrome (n = 5), and BBB permeability and vascular reactivity were compared. Plasma from women with HELLP syndrome increased BBB permeability while not changing myogenic tone and reactivity to pressure. Addition of the nitric oxide (NO) synthase inhibitor Nω-nitro-L-arginine methyl ester caused constriction of arteries that was not different with the different plasmas nor was dilation to the NO donor sodium nitroprusside different between the 2 groups. However, dilation to the small- and intermediate-conductance, calcium-activated potassium channel activator NS309 was decreased in vessels exposed to HELLP plasma. Thus, increased BBB permeability in response to HELLP plasma was associated with selective endothelial dysfunction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth. 2009;9:8.
Abildgaard U, Heimdal K. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol. 2013;166:117–123.
Vigil-de Gracia P, Tenorio-Maranon F, Cejudo-Carranza E, Helquera-Martinez A, Garcia-Caceres E. Difference between preeclampsia, HELLP syndrome and eclampsia, maternal evaluation. Ginecol Obstet Mex. 1996;64:377–382.
Habli M, Eftekhari N, Wiebracht E, et al. Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. Am J Obstet Gynecol. 2009;201(4):385.e1–e5.
Altamura C, Vasapollo B, Tibuzzi F, et al. Postpartum cerebellar infarction and haemolysis, elevated liver enzymes, low platelet (HELLP) syndrome. Neurol Sci. 2005;26(1):40–42.
Cipolla M. Cerebrovascular function in pregnancy and eclampsia. Hypertension. 2007;50(1):14–24.
Euser A, Cipolla M. Cerebral blood flow autoregulation and edema formation during pregnancy in anesthetized rats. Hypertension. 2007;49(2):334–340.
Foyouzi N, Norwitz E, Tsen L, Buhimschi C, Buhimschi I. Placental growth factor in the cerebrospinal fluid of women with preeclampsia. Int J Gynaecol Obstet. 2006;92(1):32–37.
Schreurs M, Houston E, May V, Cipolla M. The adaptation of the blood–brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy. FASEB J. 2012;26(1):355–362.
Amburgey O, Chapman A, May V, Bernstein I, Cipolla M. Plasma from preeclamptic women increases blood–brain barrier permeability. Hypertension. 2010;56(5):1003–1008.
Wallace K, Martin J Jr, Tam Tam K, et al. Seeking the mechanisms of action for corticosteroids in HELLP syndrome: SMASH study. Am J Obstet Gynecol. 2013;208(5):e1–e8.
American College of Obstetricians and Gynecologists. Diagnosis and Management of Preeclampsia and Eclampsia. Practice Bulletin 33. Washington, DC: ACOG; 2002.
Roberts T, Chapman A, Cipolla M. PPAR-gamma agonist rosiglitazone reverses increased cerebral venous hydraulic conductivity during hypertension. Am J Physiol Heart Circ Physiol. 2009;297:H1347–H1353.
Schreurs M, Cipolla M. Cerebrovascular dysfunction and blood–brain barrier permeability induced by oxidized LDL are prevented by apocynin and magnesium sulfate in female rats. J Cardiovasc Pharmacol. 2014;63(1):33–39.
Hinton J, Langton P. Inhibition of EHDF by two new combinations of K+-channel inhibitors in rat isolated arteries. Br J Pharmacol. 2003;138(6):1031–1035.
Hannah R, Dunn K, Bonev A, Nelson M. Endothelial SKCA and IKCA channels regulate brain parenchymal arteriolar diameter and cortical cerebral blood flow. J Cereb Blood Flow Metab. 2011; 31(5):1175–1186.
Sonkusare S, Bonev A, Ledoux J, et al. Elementary Ca2+ signals through endothelial TRPV4 channels regulate vascular function. Science. 2012;336(6081):597–601.
Takata F, Dohgu S, Yamauchi A, et al. In vitro blood–brain barrier models using brain capillary endothelial cells isolated from neonatal and adult rats retain age-related barrier properties. PLoS One. 2013;8(1):e55166.
Nakagawa S, Deli MA, Kawaguchi H, et al. A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int. 2009;54(3–4): 253–263.
Saraf S, Egbert NM, Mittal G, Homel P, Minkoff H, Fisher N. Predictors of posterior reversible encephalopathy syndrome in preeclampsia and eclampsia. Obstet Gynecol. 2014;123(S1):169S.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wallace, K., Tremble, S.M., Owens, M.Y. et al. Plasma From Patients With HELLP Syndrome Increases Blood—Brain Barrier Permeability. Reprod. Sci. 22, 278–284 (2015). https://doi.org/10.1177/1933719114549844
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719114549844